SEK 258
Key Takeaways
Risk factor
Resilient to price shocks
Profitability factor
Overvalued vs peers
About
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers,...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA, trading
Target Price
The average target price of MCOV-B.ST is 257 and suggests 0% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to
